A role for HLA‐DO as a co‐chaperone of HLA‐DM in peptide loading of MHC class II molecules
暂无分享,去创建一个
C. Théry | G. Hämmerling | S. Amigorena | A. Vogt | H. Kropshofer | G. Moldenhauer | E. Armandola | Bi‐Chen Li | Bi-Chen Li
[1] P. A. Peterson,et al. Altered antigen presentation in mice lacking H2-O. , 1998, Immunity.
[2] A. Rudensky,et al. Invariant Chain–independent Function of H-2M in the Formation of Endogenous Peptide–Major Histocompatibility Complex Class II Complexes In Vivo , 1998, The Journal of experimental medicine.
[3] Kevin E. Swier,et al. A critical, invariant chain-independent role for H2-M in antigen presentation. , 1998, Journal of immunology.
[4] L. Van Kaer,et al. MHC class II expression in double mutant mice lacking invariant chain and DM functions. , 1998, Journal of immunology.
[5] J. Trowsdale,et al. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading , 1997, Current Biology.
[6] P. Cresswell,et al. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. , 1997, Science.
[7] C. Benoist,et al. Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[8] D. Douek,et al. HLA-DO is an intracellular class II molecule with distinctive thymic expression. , 1997, International immunology.
[9] G. Hämmerling,et al. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. , 1997, Immunity.
[10] J. Frydman,et al. Chaperones get in touch: the Hip-Hop connection. , 1997, Trends in biochemical sciences.
[11] G. Hämmerling,et al. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? , 1997, Immunology today.
[12] B. Carreno,et al. Are transporter associated with antigen processing (TAP) and tapasin class I MHC chaperones? , 1997, Journal of immunology.
[13] S. Pierce,et al. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. , 1996, Journal of immunology.
[14] P. Cresswell,et al. HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules , 1996, The Journal of experimental medicine.
[15] G. Hämmerling,et al. Editing of the HLA‐DR‐peptide repertoire by HLA‐DM. , 1996, The EMBO journal.
[16] J. Trowsdale,et al. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs , 1996, The Journal of experimental medicine.
[17] A. Sant,et al. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules , 1996, The Journal of experimental medicine.
[18] B. Evavold,et al. Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.
[19] G. Hämmerling,et al. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Jackson,et al. HLA‐DO is a lysosomal resident which requires association with HLA‐DM for efficient intracellular transport. , 1996, The EMBO journal.
[21] P. Cresswell,et al. HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. , 1996, Immunity.
[22] P. A. Peterson,et al. Antigen Presentation and T Cell Development in H2-M-Deficient Mice , 1996, Science.
[23] H. Ruley,et al. H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection , 1996, Cell.
[24] C. Benoist,et al. Mice Lacking H2-M Complexes, Enigmatic Elements of the MHC Class II Peptide-Loading Pathway , 1996, Cell.
[25] G. Hämmerling,et al. Self-Release of CLIP in Peptide Loading of HLA-DR Molecules , 1995, Science.
[26] B. Dobberstein,et al. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. , 1995, Journal of immunology.
[27] P. A. Peterson,et al. The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. , 1995, Immunity.
[28] J. Bonifacino,et al. A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments , 1995, The Journal of cell biology.
[29] K. Mason,et al. Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC. , 1995, International immunology.
[30] G. Hämmerling,et al. Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide binding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Weber,et al. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.
[32] P. Cresswell,et al. HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.
[33] D. Zaller,et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.
[34] P. Cresswell,et al. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles , 1995, The Journal of experimental medicine.
[35] A Sette,et al. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II , 1995, The Journal of experimental medicine.
[36] J. Trowsdale,et al. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. , 1994, Science.
[37] P. Cresswell,et al. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. , 1994, Immunity.
[38] P. Cresswell,et al. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. , 1994, Immunity.
[39] J. Strominger,et al. Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH , 1994, The Journal of experimental medicine.
[40] H. Ploegh,et al. Mapping functional regions in the lumenal domain of the class II- associated invariant chain , 1994, The Journal of experimental medicine.
[41] Jeffrey A. Shaman,et al. An essential role for HLA–DM in antigen presentation by class II major histocompatibility molecules , 1994, Nature.
[42] B. Arp,et al. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells , 1994, Nature.
[43] M. Taylor,et al. Endosomal aspartic proteinases are required for invariant-chain processing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] G. Carcelain,et al. Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. , 1993, Cancer research.
[45] R. Germain,et al. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules , 1993, Nature.
[46] S. Ceman,et al. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. , 1992, Science.
[47] P. Cresswell,et al. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.
[48] H. Kalbacher,et al. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets. , 1991, Biochemistry.
[49] R. Germain,et al. A role for peptide in determining MHC class II structure , 1991, Nature.
[50] R. Germain,et al. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding , 1991, Nature.
[51] H. Geuze,et al. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.
[52] P. A. Peterson,et al. Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.
[53] O. Bakke,et al. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.
[54] P. Cresswell,et al. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.
[55] B. Arp,et al. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes , 1990, Nature.
[56] K. Arai,et al. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat , 1988, Molecular and cellular biology.
[57] P. A. Peterson,et al. Class II genes of the human major histocompatibility complex. The DO beta gene is a divergent member of the class II beta gene family. , 1987, The Journal of biological chemistry.
[58] Eric O Long,et al. DO beta: a new beta chain gene in HLA‐D with a distinct regulation of expression. , 1985, The EMBO journal.
[59] J. Trowsdale,et al. The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions. , 1985, The EMBO journal.
[60] J. Bodmer,et al. Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens. , 1983, Immunology.
[61] L. Lampson,et al. Two populations of Ia-like molecules on a human B cell line. , 1980, Journal of immunology.
[62] R. Zahler. Enzyme Structure and Mechanism , 1979, The Yale Journal of Biology and Medicine.
[63] J. Trowsdale,et al. Association between HLA-DM and HLA-DR in vivo. , 1996, Immunity.
[64] D. O'reilly,et al. Baculovirus expression vectors: a laboratory manual. , 1992 .
[65] M. Ashburner. A Laboratory manual , 1989 .